Enhanced imaging techniques could improve medical diagnosis

September 19, 2005

Chris Wyatt is a Virginia Tech electrical engineer who is attempting to provide the medical community with better, quicker, and more relevant images of the human body. The side effects are not bad either -- lower medical costs, new treatments, and earlier disease detection.

Today, doctors and researchers can view the body's hard and soft tissues through X-rays, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) technology. With MRI and positron emission tomography (PET) scans, viewing cellular activity is also possible.

But these viewing techniques can be enhanced. Wyatt is specifically looking at improving imaging for virtual colonoscopies; developing algorithms to replace extensive manual work in brain imaging; and developing image-guided polypectomy technology.

As an example of the impact that smarter imaging techniques could have, consider the pharmaceutical industry and its drug trials. "Drug studies involve many hundreds of patients; that's a lot of data. If you're evaluating a new drug for cancer and you scan 1,000 patients three times, you have 3,000 sets of data. Can you hire a radiologist to look at all that?

"You can acquire the data, but pulling out the information you want -- such as how the lesion is changing - is a difficult, time-consuming process that right now is done manually in many cases. Trained technicians look at the images and outline the lesions by hand," said Wyatt, a faculty member in the Virginia Tech - Wake Forest University School of Biomedical Engineering and Sciences.

In brain imaging, Wyatt is concentrating on improving the medical understanding of addiction through modeling techniques. Wyatt is working with the Wake Forest University School of Medicine's Center for the Neurobehavorial Study of Alcohol (CNSA) to develop algorithms that increase the medical understanding of neurological structures beyond what is currently provided by state-of-the-art MRIs. Wyatt hopes to produce an MRI brain template for two species of macaque monkeys and verify his results using the animals in ongoing studies of alcohol abuse and alcoholism.

"Monkeys are a unique tool for alcoholism research because several aspects of their alcohol consumption closely mimic those of humans," Wyatt said. "Using monkey models and magnetic resonance imaging, it is possible to design complex studies to understand the neurological mechanisms of alcoholism without the confounding factors problematic in human research. However, current neuro-image analysis tools were designed for use on human data and do not provide the same level of accuracy and robustness when applied to monkey data," he explained. Wyatt's goal is to develop a comprehensive set of tools for the analysis of monkey images.

If Wyatt is able to improve medicine's understanding of the biological mechanisms of addiction, then he will also increase the knowledge about the influence of risk factors and the effects on the body. "As many of these mechanisms are primarily located in the brain, understanding the neurological effects of alcohol and related factors is a key aspect of alcoholism research. This knowledge is critical to diagnosis, treatment, and prevention of alcoholism," Wyatt said.

Computer-aided diagnosis could also improve the quality of evaluations. "The problem with evaluating all these images manually is that you use different people at different skill levels at different times of the day. People inherently introduce inconsistencies, whereas computers are more consistent and reliable if programmed correctly."

Wyatt is also pursing imaging advancements in the detection and treatment of colon cancer. "About 50 percent of today's colon cancer cases could have been prevented with early detection of polyps. Doctors have the screening methods, but compliance is a problem. Colonoscopies are not fun. If we can do the initial screening with more comfortable imaging instead of scoping, we can get higher compliance and detect more cases early," he said.

He is working to extend the virtual colonoscopy technology to image-guided polypectomy. "The polyps still need to be surgically removed, but patients who already know they have polyps are much more amenable to enduring a scope. A well-trained endoscopist, if there is no problem with insertion, is very fast and very good. Sometimes, though, the polyps can hide in a fold and finding them can be difficult. If we can use virtual colonoscopy to help guide the endoscope to the polyps, we can help the endoscopists become even better and faster."

While earning his Ph.D. at the Wake Forest University School of Medicine, Wyatt worked in its Virtual Colonoscopy Laboratory, which uses CT data to image the colon.

"My efforts are in connecting prior information to analyze the data we get from different imaging," he said. The prior information encompasses anatomy, physiology, and imaging experience. "Physicians and radiologists use prior knowledge of the organs and prior experience in reading images," he explained. "When they look at an image, even if it's not a good image, they impose their knowledge to extract usable information. We've been working for some time to develop algorithms to incorporate this kind of knowledge into the operating systems of imaging equipment."

Virginia Tech

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.